The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


100 unit(s)/millilitre Solution for injection

Sanofi-Aventis Deutschland GmbHEU/1/04/285/021-036

Main Information

Trade NameApidra
Active SubstancesInsulin glulisine
Strength100 unit(s)/millilitre
Dosage FormSolution for injection
Licence HolderSanofi-Aventis Deutschland GmbH
Licence NumberEU/1/04/285/021-036

Group Information

ATC CodeA10AB Insulins and analogues for injection, fast-acting
A10AB06 insulin glulisine


Licence Issued12/01/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back